Apellis Pharmaceuticals Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.
/ 
Frequently asked questions
To buy Apellis Pharmaceuticals Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Apellis Pharmaceuticals Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Apellis Pharmaceuticals Inc. is APLS:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Apellis Pharmaceuticals Inc. has its primary listing on NASDAQ. You can trade Apellis Pharmaceuticals Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Apellis Pharmaceuticals Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Apellis Pharmaceuticals Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Apellis Pharmaceuticals Inc..